Expand Document  |  Expand Chapter  |  Full TOC  |  Printable HTML version
Scaling up Antiretroviral Therapy in Resource Limited Settings : Guidelines for a Public Health Approach
(2002; 163 pages) [French] View the PDF document
Table of Contents
View the documentAbbreviations
View the documentPreface
View the documentSummary
View the documentI. Introduction
View the documentII. Objectives of the document
View the documentIII. Background and purpose
View the documentIV. Approach to antiretroviral therapy
View the documentV. When to start antiretroviral therapy in adults and adolescents
View the documentVI. Recommended first-line regimens for adults and adolescents
View the documentVII. When to change therapy in adults and adolescents
View the documentVIII. Recommended second-line regimens in adults and adolescents
View the documentIX. Drug resistance
View the documentX. Antiretroviral therapy in women, with specific reference to pregnancy
View the documentXI. Infants and children
View the documentXII. Tuberculosis and other HIV-related conditions
View the documentXIII. Injecting drug users
View the documentXIV. Drug adherence
Open this folder and view contentsXV. Monitoring antiretroviral therapy
View the documentReferences
View the documentInterim WHO Antiretroviral Treatment Working Group, Geneva, 19-20 november 2001
View the documentWHO International Consultative Meeting on HIV/AIDS Antiretroviral Therapy, 22-23 May 2001, Geneva
 

Scaling up Antiretroviral Therapy in Resource Limited Settings : Guidelines for a Public Health Approach

GUIDELINES FOR A
PUBLIC HEALTH APPROACH

World Health Organization
Department of HIV/AIDS
Family and Community Health Cluster

WHO Library Cataloguing-in-Publication Data

Scaling up antiretroviral therapy in resource-limited settings: guidelines for a public health approach: executive summary.

1. Anti-HIV agents - therapeutic use 2. Anti-HIV agents - administration and dosage 3. HIV infections - drug therapy 4. Treatment failure

5. Exposed population 6. Adult 7. Child 8. Guidelines

(ISBN 92 4 154567 4)

(NLM classification: QV 268.5)

The World Health Organization welcomes requests for permission to reproduce or translate its publications, in part or in full. Applications and enquiries should be addressed to the Office of Publications, World Health Organization, CH-1211 Geneva 27, Switzerland, which will be glad to provide the latest information on any changes made to the text, plans for new editions, and reprints and translations already available.

© World Health Organization 2002

Publications of the World Health Organization enjoy copyright protection in accordance with the provisions of Protocol 2 of the Universal Copyright Convention. All rights reserved.

The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries.

The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.

Typeset and printed in

This document would not have been possible without the input of the numerous national and international experts who have participated in the consultations that led to the formulation of these guidelines.

The guidelines on
“Scaling up antiretroviral therapy in resource-limited settings, Guidelines for a public health approach”
were edited by
Scott Hammer, Columbia University,
New York City, USA
Editor in Chief

Diana Gibb, British Medical Research Council,
London, U.K.
Editor, Pediatric Chapter

Diane Havlir, University of California at
San Diego, USA,
Editor, HIV related Co-infections Chapter

Lynne Mofenson, National Institutes of Health,
NICHD, Bethesda, USA
Editor, Pregnancy Chapter

Ingrid Van Beek, Sydney Hospital,
Sydney, Australia,
Editor, Injection Drug User’s Chapter

Stefano Vella, Instituto Superiore de Sanita,
Rome, Italy
Editor, Clinical and Laboratory Monitoring of ARV use Chapter

Overall coordination
Basil Vareldzis and Jos Perriëns
of the HIV/AIDS Department of WHO, Geneva

The World Health Organization would like to express its special thanks to the others members of the Writing Committee including Kenneth Chebet, Mark Dybul, Carlo Giaquinto, Elly Katabira, Christine Katlama, Jean Elie Malkin, James McIntyre, Souleyman M’Boup, Jacques Mokhbat, Joia Mukherjee, Praphan Phanupak, Mauro Schechter, Marco Antonio de Avila Vitoria.

The World Health Organization would also like to acknowledge comments from many experts including: Suzanne Crow, Kevin DeCock, Jean Emmanuel, Charles Gilks, J. Gölz, Julian Gold, Gregg Gonsalves, Ian Grubb, Vincent Habiyambere, Hans Hogerzeil, Arata Kochi, Eric van Praag, S. S. Lee, Paul Nunn, Mark Harrington, Robert Soliz, Eve Lakritz, Gaby Vercauteren and Bernhard Schwartländer.

WHO acknowledges the generous contribution of NIH in the development of the guidelines.

Full guidelines available at http://www.who.int

For orders, contact:
WORLD HEALTH ORGANIZATION - Family and Community Health Cluster - Department of HIV/AIDS
20, avenue Appia - CH-1211 Geneva 27 - SWITZERLAND - E-mail: hiv-aids@who.int

to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 7, 2014